STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Larimar Therapeutics, Inc.

Filed

January 19, 2024

Period of Report

January 17, 2024

Accession Number

0001062993-24-001083